Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Sibai

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pharmacology, Biochemistry, and Behavior|February 14, 2021
Sleep and alertness disturbance and substance use disorders: A bi-directional relationTimothy Roehrs, Mohammad Sibai, Thomas Roth
Psychopharmacology|May 9, 2025
A Mechanistic study assessing difficulty discontinuing chronic hypnotic useTimothy Roehrs, Gail Koshorek, Mohammad Sibai, et al.
The American Journal of Drug and Alcohol Abuse|December 21, 2019
A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorderMohammad Sibai, Kaitlyn Mishlen, Edward V Nunes, et al.
Journal of Substance Use|July 18, 2024
Open Label Pilot of Lorcaserin (a serotonin 2C-receptor agonist) for Cannabis Use DisorderChristina A Brezing, Mohammad Sibai, C Jean Choi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pharmacology, Biochemistry, and Behavior|February 14, 2021
Sleep and alertness disturbance and substance use disorders: A bi-directional relationTimothy Roehrs, Mohammad Sibai, Thomas Roth
Psychopharmacology|May 9, 2025
A Mechanistic study assessing difficulty discontinuing chronic hypnotic useTimothy Roehrs, Gail Koshorek, Mohammad Sibai, et al.
The American Journal of Drug and Alcohol Abuse|December 21, 2019
A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorderMohammad Sibai, Kaitlyn Mishlen, Edward V Nunes, et al.
Journal of Substance Use|July 18, 2024
Open Label Pilot of Lorcaserin (a serotonin 2C-receptor agonist) for Cannabis Use DisorderChristina A Brezing, Mohammad Sibai, C Jean Choi, et al.
Pageof 1